U.S. Pharmacy Market Size, Share & Trends Analysis Report By Product Type (Prescription, OTC), By Type (Hospital Pharmacy, Retail Chains, ePharmacy), By Ownership, And Segment Forecasts, 2025 - 2033

Table of Contents

Chapter 1. Report Scope & Research Methodology

• 1.1 Market Segmentation
  • 1.1.1 Segment Definition
    • 1.1.1.1 Product Type
    • 1.1.1.2 Type
• 1.2 Estimates and Forecast Timeline
• 1.3 Research Methodology
  • 1.3.1 Information Procurement
  • 1.3.2 Purchased Database
  • 1.3.3 Gvr's Internal Database
  • 1.3.4 Secondary Sources
  • 1.3.5 Primary Research
  • 1.3.6 Details Of Primary Research
• 1.4 Information or Data Analysis
  • 1.4.1 Data Analysis Models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Three Pillars of Market Estimation
    • 1.6.1.1 Secondary Market Research
    • 1.6.1.2 Primary Market Intelligence
      • 1.6.1.2.1 In-Depth Interviews (IDIs)
      • 1.6.1.2.2 Online Survey Program
  • 1.6.2 Market Modeling & Forecasting
    • 1.6.2.1 Model 1: Volume-Price Analysis
      • 1.6.2.1.1 Step 1: Prescription volume estimation
      • 1.6.2.1.2 Channel-Wise Methodology
        • 1.6.2.1.2.1 Retail Chains (CVS, Walgreens, etc.)
        • 1.6.2.1.2.2 Supermarket Pharmacies (Kroger, Albertsons, Publix)
        • 1.6.2.1.2.3 Health System / Hospital Outpatient Pharmacies
        • 1.6.2.1.2.4 Independent Pharmacies
        • 1.6.2.1.2.5 Mail-Order Pharmacies
        • 1.6.2.1.2.6 Specialty / Central Fill Pharmacies
        • 1.6.2.1.2.7 Long-Term Care (LTC) and Defense-Related Pharmacies
        • 1.6.2.1.2.8 ePharmacies (Amazon, Capsule, Hims & Hers, etc.)
        • 1.6.2.1.2.9 Other Channels
        • 1.6.2.1.2.10 Aggregation & Triangulation
      • 1.6.2.1.3 Step 2: Determining Average Realized Price (ARP)
      • 1.6.2.1.4 Step 2: OTC Revenue
    • 1.6.2.2 Model 2: Company Market Share Analysis
      • 1.6.2.2.1 Step 1: Public Filings
      • 1.6.2.2.2 Step 2: Private & Independent Estimates
      • 1.6.2.2.3 Step 3: Market Share Allocation
    • 1.6.2.3 CAGR/Forecasting Calculations & Assumptions
      • 1.6.2.3.1 Key Forecasting Drivers and Weights
      • 1.6.2.3.2 Scenario Framework (2025-2033)
      • 1.6.2.3.3 Factor-Based Impact Assessment
  • 1.6.3 Estimation Process: Pharmacy Type Split By Catchment Area
    • 1.6.3.1 Data Sources
    • 1.6.3.2 Estimation Process
  • 1.6.4 Estimation Process: Pharmacy Type Split By Product Form
  • 1.6.5 Company-Level Metric's Estimation
    • 1.6.5.1 Financial Performance
      • 1.6.5.1.1 2024 Revenue & EBITDA (Pharmacy-Only)
      • 1.6.5.1.2 5-Year Forecast of Revenue & EBITDA
      • 1.6.5.1.3 Balance Sheet Health Indicators
    • 1.6.5.2 Volumes & Operations
      • 1.6.5.2.1 2024 Total Prescriptions; 5-Year Rx Forecast
      • 1.6.5.2.2 % Fulfilled via Central Fill; Volumes Split by Catchment Area
• 1.7 List of Secondary Sources
• 1.8 List of Abbreviations
• 1.9 Research Objectives
  • 1.9.1 Objective - 1
  • 1.9.2 Objective - 2
  • 1.9.3 Objective - 3

Chapter 2. Executive Summary

• 2.1 Market Snapshot
• 2.2 Segment Outlook - I
• 2.3 Segment Outlook- II
• 2.4 Competitive Scenario

Chapter 3. U.S. Pharmacy Market - Industry Outlook

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent Market Outlook
  • 3.1.2 Related Market Outlook
    • 3.1.2.1 U.S. pharmacy benefit management market
• 3.2 Market Dynamics
  • 3.2.1 Market Driver Analysis
    • 3.2.1.1 Increasing prevalence of chronic diseases
    • 3.2.1.2 Technological advancements
    • 3.2.1.3 Expanding health insurance coverage
    • 3.2.1.4 Increasing demand for specialty drugs
  • 3.2.2 Market Restraint Analysis
    • 3.2.2.1 Product recalls and lawsuits
    • 3.2.2.2 Lack of trained staff
  • 3.2.3 Market Opportunity Analysis
  • 3.2.4 Market Challange Analysis
• 3.3 Regulatory Scenario & Reimbursement Outlook
  • 3.3.1 Regulatory Scenario
  • 3.3.2 Reimbursement Scenario
• 3.4 Business Environment Analysis Tools
  • 3.4.1 Porter's Five Forces Analysis
  • 3.4.2 Pestle Analysis

Chapter 4. U.S. Pharmacy Market: Product Type Estimates & Trend Analysis

• 4.1 U.S. Pharmacy Market: Product Type Segment Dashboard
• 4.2 Product Type Movement & Market Share Analysis, 2024 & 2033
• 4.3 U.S. Pharmacy Market Size & Forecast and Forecasts, By Product Type (USD Billion)
  • 4.3.1 Prescription
    • 4.3.1.1 Prescription market, 2021-2033 (USD Billion)
  • 4.3.2 Over-the-Counter (OTC)
    • 4.3.2.1 OTC market, 2021-2033 (USD Billion)

Chapter 5. U.S. Pharmacy Market: Type Estimates & Trend Analysis

• 5.1 U.S. Pharmacy Market: Type Segment Dashboard
• 5.2 Type Movement & Market Share Analysis, 2024 & 2033
• 5.3 U.S. Pharmacy Market Size & Forecast and Forecasts, By Type, 2021 - 2033 (USD Billion)
• 5.4 U.S. Pharmacy Market: Estimated Number of Pharmacies, By Type, 2021 - 2033 (Unit)
• 5.5 U.S. Pharmacy Market: Estimated Prescription Volume, By Type, 2021 - 2033 (Million)
• 5.6 U.S. Pharmacy Market: Estimated Prescription Volume, By Catchment Area, 2024 (%)
• 5.7 U.S. Pharmacy Market: Estimated Prescription Volume, By Filled Prescriptions (TRx), 2024 (%)
  • 5.7.1 Retail Chains
    • 5.7.1.1 Retail chains market, 2021 - 2033 (USD Billion)
  • 5.7.2 Supermarket Pharmacies
    • 5.7.2.1 Supermarket pharmacies market, 2021 - 2033 (USD Billion)
  • 5.7.3 Health System / Hospital Pharmacy
    • 5.7.3.1 Health system / Hospital pharmacy market, 2021 - 2033 (USD Billion)
  • 5.7.4 Independent Pharmacies
    • 5.7.4.1 Independent pharmacies market, 2021 - 2033 (USD Billion)
  • 5.7.5 Mail-Order Pharmacies
    • 5.7.5.1 Mail-order pharmacy market, 2021 - 2033 (USD Billion)
  • 5.7.6 Specialty / Central Fill Pharmacies
    • 5.7.6.1 Specialty / central fill pharmacies market, 2021 - 2033 (USD Billion)
  • 5.7.7 Long-Term Care And Defense-Related Pharmacies
    • 5.7.7.1 Long-term care and defense-related pharmacies market, 2021 - 2033 (USD Billion)
  • 5.7.8 Epharmacy
    • 5.7.8.1 ePharmacy market, 2021 - 2033 (USD Billion)
  • 5.7.9 Others
    • 5.7.9.1 Others market, 2021 - 2033 (USD Billion)

Chapter 6. U.S. Pharmacy Market Competitive Analysis

• 6.1 Company Categorization
• 6.2 Estimated Company Market Share Analysis, 2024
  • 6.2.1 CVS Pharmacy
    • 6.2.1.1 Company Overview
    • 6.2.1.2 Financial Performance
      • 6.2.1.2.1 Revenue (pharmacy-only where available/estimable), 2024 - 2029 (USD Million)
      • 6.2.1.2.2 EBITDA (%) & EBITDA Margin (2024)
      • 6.2.1.2.3 Balance sheet health metrics (2024)
    • 6.2.1.3 Volumes & Operations
      • 6.2.1.3.1 Estimated prescription volumes; 2024 - 2029 (Million)
      • 6.2.1.3.2 % of prescriptions fulfilled via central fill (2024)
      • 6.2.1.3.3 % of prescriptions fulfilled by catchment areas (2024)
    • 6.2.1.4 Value Chain Position
      • 6.2.1.4.1 Current wholesaler(s), distributor(s), and GPO affiliations (if applicable)
      • 6.2.1.4.2 Ownership (public/private), parent/subsidiaries, recent M&A divestments
    • 6.2.1.5 Central Fulfillment (if used/planned)
      • 6.2.1.5.1 Strategy
      • 6.2.1.5.2 Requirements
      • 6.2.1.5.3 Technology provider(s) and hardware/automation
      • 6.2.1.5.4 Partnerships
    • 6.2.1.6 Strategy Mapping/ Major Deals & Strategic Alliances Analysis
  • 6.2.2 Walgreens Boots Alliance, Inc.
    • 6.2.2.1 Company Overview
    • 6.2.2.2 Financial Performance
      • 6.2.2.2.1 Revenue (pharmacy-only where available/estimable), 2024 - 2029 (USD Million)
      • 6.2.2.2.2 EBITDA (%) & EBITDA Margin (2024)
      • 6.2.2.2.3 Balance sheet health metrics (2024)
    • 6.2.2.3 Volumes & Operations
      • 6.2.2.3.1 Estimated prescription volumes; 2024 - 2029 (Million)
      • 6.2.2.3.2 % of prescriptions fulfilled via central fill (2024)
      • 6.2.2.3.3 % of prescriptions fulfilled by catchment areas (2024)
    • 6.2.2.4 Value Chain Position
      • 6.2.2.4.1 Current wholesaler(s), distributor(s), and GPO affiliations (if applicable)
      • 6.2.2.4.2 Ownership (public/private), parent/subsidiaries, recent M&A divestments
    • 6.2.2.5 Central Fulfillment (if used/planned)
      • 6.2.2.5.1 Strategy
      • 6.2.2.5.2 Requirements
      • 6.2.2.5.3 Technology provider(s) and hardware/automation
      • 6.2.2.5.4 Partnerships
    • 6.2.2.6 Strategy Mapping/ Major Deals & Strategic Alliances Analysis
  • 6.2.3 Scriptco Pharmacy
    • 6.2.3.1 Company Overview
    • 6.2.3.2 Financial Performance
      • 6.2.3.2.1 Revenue (pharmacy-only where available/estimable), 2024 - 2029 (USD Million)
      • 6.2.3.2.2 EBITDA (%) & EBITDA Margin (2024)
      • 6.2.3.2.3 Balance sheet health metrics (2024)
    • 6.2.3.3 Volumes & Operations
      • 6.2.3.3.1 Estimated prescription volumes; 2024 - 2029 (Million)
      • 6.2.3.3.2 % of prescriptions fulfilled via central fill (2024)
    • 6.2.3.4 Value Chain Position
      • 6.2.3.4.1 Current wholesaler(s), distributor(s), and GPO affiliations (if applicable)
      • 6.2.3.4.2 Ownership (public/private), parent/subsidiaries, recent M&A divestments
    • 6.2.3.5 Central Fulfillment (if used/planned)
      • 6.2.3.5.1 Strategy
      • 6.2.3.5.2 Requirements
      • 6.2.3.5.3 Technology provider(s) and hardware/automation
      • 6.2.3.5.4 Partnerships
    • 6.2.3.6 Strategy Mapping/ Major Deals & Strategic Alliances Analysis
  • 6.2.4 Walmart Pharmacy
    • 6.2.4.1 Company Overview
    • 6.2.4.2 Financial Performance
      • 6.2.4.2.1 Revenue (pharmacy-only where available/estimable), 2024 - 2029 (USD Million)
      • 6.2.4.2.2 EBITDA (%) & EBITDA Margin (2024)
      • 6.2.4.2.3 Balance sheet health metrics (2024)
    • 6.2.4.3 Volumes & Operations
      • 6.2.4.3.1 Estimated prescription volumes; 2024 - 2029 (Million)
      • 6.2.4.3.2 % of prescriptions fulfilled via central fill (2024)
      • 6.2.4.3.3 % of prescriptions fulfilled by catchment areas (2024)
    • 6.2.4.4 Value Chain Position
      • 6.2.4.4.1 Current wholesaler(s), distributor(s), and GPO affiliations (if applicable)
      • 6.2.4.4.2 Ownership (public/private), parent/subsidiaries, recent M&A divestments
    • 6.2.4.5 Central Fulfillment (if used/planned)
      • 6.2.4.5.1 Strategy
      • 6.2.4.5.2 Requirements
      • 6.2.4.5.3 Technology provider(s) and hardware/automation
      • 6.2.4.5.4 Partnerships
    • 6.2.4.6 Strategy Mapping/ Major Deals & Strategic Alliances Analysis
  • 6.2.5 Avita Pharmacy
    • 6.2.5.1 Company Overview
    • 6.2.5.2 Financial Performance
      • 6.2.5.2.1 Revenue (pharmacy-only where available/estimable), 2024 - 2029 (USD Million)
      • 6.2.5.2.2 EBITDA (%) & EBITDA Margin (2024)
      • 6.2.5.2.3 Balance sheet health metrics (2024)
    • 6.2.5.3 Volumes & Operations
      • 6.2.5.3.1 Estimated prescription volumes; 2024 - 2029 (Million)
      • 6.2.5.3.2 % of prescriptions fulfilled via central fill (2024)
    • 6.2.5.4 Value Chain Position
      • 6.2.5.4.1 Current wholesaler(s), distributor(s), and GPO affiliations (if applicable)
      • 6.2.5.4.2 Ownership (public/private), parent/subsidiaries, recent M&A divestments
    • 6.2.5.5 Central Fulfillment (if used/planned)
      • 6.2.5.5.1 Strategy
      • 6.2.5.5.2 Requirements
      • 6.2.5.5.3 Technology provider(s) and hardware/automation
      • 6.2.5.5.4 Partnerships
    • 6.2.5.6 Strategy Mapping/ Major Deals & Strategic Alliances Analysis
  • 6.2.6 The Kroger Co.
    • 6.2.6.1 Company Overview
    • 6.2.6.2 Financial Performance
      • 6.2.6.2.1 Revenue (pharmacy-only where available/estimable), 2024 - 2029 (USD Million)
      • 6.2.6.2.2 EBITDA (%) & EBITDA Margin (2024)
      • 6.2.6.2.3 Balance sheet health metrics (2024)
    • 6.2.6.3 Volumes & Operations
      • 6.2.6.3.1 Estimated prescription volumes; 2024 - 2029 (Million)
      • 6.2.6.3.2 % of prescriptions fulfilled via central fill (2024)
      • 6.2.6.3.3 % of prescriptions fulfilled by catchment areas (2024)
    • 6.2.6.4 Value Chain Position
      • 6.2.6.4.1 Current wholesaler(s), distributor(s), and GPO affiliations (if applicable)
      • 6.2.6.4.2 Ownership (public/private), parent/subsidiaries, recent M&A divestments
    • 6.2.6.5 Central Fulfillment (if used/planned)
      • 6.2.6.5.1 Strategy
      • 6.2.6.5.2 Requirements
      • 6.2.6.5.3 Technology provider(s) and hardware/automation
      • 6.2.6.5.4 Partnerships
    • 6.2.6.6 Strategy Mapping/ Major Deals & Strategic Alliances Analysis
  • 6.2.7 Albertsons Companies, Inc.
    • 6.2.7.1 Company Overview
    • 6.2.7.2 Financial Performance
      • 6.2.7.2.1 Revenue (pharmacy-only where available/estimable), 2024 - 2029 (USD Million)
      • 6.2.7.2.2 EBITDA (%) & EBITDA Margin (2024)
      • 6.2.7.2.3 Balance sheet health metrics (2024)
    • 6.2.7.3 Volumes & Operations
      • 6.2.7.3.1 Estimated prescription volumes; 2024 - 2029 (Million)
      • 6.2.7.3.2 % of prescriptions fulfilled via central fill (2024)
      • 6.2.7.3.3 % of prescriptions fulfilled by catchment areas (2024)
    • 6.2.7.4 Value Chain Position
      • 6.2.7.4.1 Current wholesaler(s), distributor(s), and GPO affiliations (if applicable)
      • 6.2.7.4.2 Ownership (public/private), parent/subsidiaries, recent M&A divestments
    • 6.2.7.5 Central Fulfillment (if used/planned)
      • 6.2.7.5.1 Strategy
      • 6.2.7.5.2 Requirements
      • 6.2.7.5.3 Technology provider(s) and hardware/automation
      • 6.2.7.5.4 Partnerships
    • 6.2.7.6 Strategy Mapping/ Major Deals & Strategic Alliances Analysis
  • 6.2.8 Costco Wholesale Corporation.
    • 6.2.8.1 Company Overview
    • 6.2.8.2 Financial Performance
      • 6.2.8.2.1 Revenue (pharmacy-only where available/estimable), 2024 - 2029 (USD Million)
      • 6.2.8.2.2 EBITDA (%) & EBITDA Margin (2024)
      • 6.2.8.2.3 Balance sheet health metrics (2024)
    • 6.2.8.3 Volumes & Operations
      • 6.2.8.3.1 Estimated prescription volumes; 2024 - 2029 (Million)
      • 6.2.8.3.2 % of prescriptions fulfilled via central fill (2024)
      • 6.2.8.3.3 % of prescriptions fulfilled by catchment areas (2024)
    • 6.2.8.4 Value Chain Position
      • 6.2.8.4.1 Current wholesaler(s), distributor(s), and GPO affiliations (if applicable)
      • 6.2.8.4.2 Ownership (public/private), parent/subsidiaries, recent M&A divestments
    • 6.2.8.5 Central Fulfillment (if used/planned)
      • 6.2.8.5.1 Strategy
      • 6.2.8.5.2 Requirements
      • 6.2.8.5.3 Technology provider(s) and hardware/automation
      • 6.2.8.5.4 Partnerships
    • 6.2.8.6 Strategy Mapping/ Major Deals & Strategic Alliances Analysis
  • 6.2.9 Sam's West, Inc.
    • 6.2.9.1 Company Overview
    • 6.2.9.2 Value Chain Position
      • 6.2.9.2.1 Current wholesaler(s), distributor(s), and GPO affiliations (if applicable)
      • 6.2.9.2.2 Ownership (public/private), parent/subsidiaries, recent M&A divestments
    • 6.2.9.3 Central Fulfillment (if used/planned)
      • 6.2.9.3.1 Strategy
      • 6.2.9.3.2 Requirements
      • 6.2.9.3.3 Technology provider(s) and hardware/automation
      • 6.2.9.3.4 Partnerships
    • 6.2.9.4 Strategy Mapping/ Major Deals & Strategic Alliances Analysis

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviation
• Table 3 Specialty Drug Expenditures, 2016 - 2021
• Table 4 U.S. Pharmacy Market Revenue Estimates and Forecast, By Product Type, 2021 - 2033 (USD Billion)
• Table 5 U.S. Pharmacy Market Revenue Estimates and Forecast, By Type, 2021 - 2033 (USD Billion)
• Table 6 U.S. Pharmacy Market: Estimated Number of Pharmacies, By Type, 2021 - 2033 (Unit)
• Table 7 U.S. Pharmacy Market: Estimated Prescription Volume, By Type, 2021 - 2033 (Million)
• Table 8 U.S. Pharmacy Market Revenue Estimates and Forecast, By Ownership, 2021 - 2033 (USD Billion)
• Table 9 U.S. Pharmacy Market: Estimated Prescription Volume, By Catchment Area, 2024 (%)
• Table 10 U.S. Pharmacy Market: Estimated Prescription Volume, By Filled Prescriptions (TRX), 2024 (%)

List of Figures

• Fig. 1 U.S. Pharmacy Market Segmentation
• Fig. 2 Market Research Process
• Fig. 3 Information Procurement
• Fig. 4 Primary Research Pattern
• Fig. 5 Market Research Approaches
• Fig. 6 Value-Chain-Based Sizing & Forecasting
• Fig. 7 Market Formulation & Validation
• Fig. 8 Market Snapshot
• Fig. 9 Segment Outlook-I
• Fig. 10 Segment Outlook-II
• Fig. 11 Competitive Scenario
• Fig. 12 U.S. Pharmacy Market: Parent Market Outlook
• Fig. 13 U.S. Pharmacy Market: Ancillary/Related Market Outlook
• Fig. 14 U.S. Pharmacy Market Dynamics
• Fig. 15 Market Driver Relevance Analysis (Current & Future Impact)
• Fig. 16 Estimated New Cancer Cases, 2024
• Fig. 17 Estimated US Prevalence of Stroke, 2018 - 2030
• Fig. 18 Estimated US Prevalence of Prostate Cancer, 2018 - 2030
• Fig. 19 Estimated US Prevalence of Kidney Cancer, 2018 - 2030
• Fig. 20 Market Restraint Relevance Analysis (Current & Future Impact)
• Fig. 21 Number of Pharmacy Degrees Conferred 2018 - 2023 By Gender
• Fig. 22 U.S. Pharmacy Market: Porter's Five Forces Analysis
• Fig. 23 U.S. Pharmacy Market: PESTLE Analysis
• Fig. 24 U.S. Pharmacy Market: Product Type Segment Dashboard
• Fig. 25 U.S. Pharmacy Market: Product Type Market Share Analysis, 2024 & 2033
• Fig. 26 Prescription Market, 2021 - 2033 (USD Billion)
• Fig. 27 OTC Market, 2021 - 2033 (USD Billion)
• Fig. 28 U.S. Pharmacy Market: Type Segment Dashboard
• Fig. 29 U.S. Pharmacy Market: Type Market Share Analysis, 2024 & 2033
• Fig. 30 Retail Pharmacy Market, 2021 - 2033 (USD Billion)
• Fig. 31 Supermarket Pharmacies Market, 2021 - 2033 (USD Billion)
• Fig. 32 Health System / Hospital Pharmacy Market, 2021 - 2033 (USD Billion)
• Fig. 33 Independent Pharmacies Market, 2021 - 2033 (USD Billion)
• Fig. 34 Mail-Order Pharmacy Market, 2021 - 2033 (USD Billion)
• Fig. 35 Specialty / Central Fill Pharmacies Market, 2021 - 2033 (USD Billion)
• Fig. 36 Long-Term Care and Defense-Related Pharmacies Market, 2021 - 2033 (USD Billion)
• Fig. 37 E-pharmacy Market, 2021 - 2033 (USD Billion)
• Fig. 38 Others Market, 2021 - 2033 (USD Billion)
• Fig. 39 U.S. Pharmacy Market: Ownership Segment Dashboard
• Fig. 40 U.S. Pharmacy Market: Ownership Market Share Analysis, 2024 & 2033
• Fig. 41 Chain Pharmacy Market, 2021 - 2033 (USD Billion)
• Fig. 42 Independent Pharmacy Market, 2021 - 2033 (USD Billion)
• Fig. 43 Key Company Categorization
• Fig. 44 Estimated Company Market Share Analysis, 2024